Cover Image

EFFICACY AND SAFETY OF ALENDRONIC ACID IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS AND OSTEOPOROSIS

Show other versions (1)

Search for and practical application of new medications to treat of osteoporosis is one of the critical issues in pediatric rheumatology. The article reviews the efficacy and safety of alendronic acid in 64 subjects with juvenile rheumatoid arthritis and systemic osteoporosis. It is demonstrated tha...

Full description

Saved in:
Bibliographic Details
Main Authors: A.O. Lisitsin (Author), E.I. Alexeeva (Author), V.G. Pinelis (Author), M.I. Bakanov (Author), S.I. Valieva (Author), T.M. Bzarova (Author), K.B. Isaeva (Author), G.V. Kuznetsova (Author), E.N. Arsen'eva (Author), R.V. Denisova (Author)
Format: Book
Published: Union of pediatricians of Russia, 2010-02-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Search for and practical application of new medications to treat of osteoporosis is one of the critical issues in pediatric rheumatology. The article reviews the efficacy and safety of alendronic acid in 64 subjects with juvenile rheumatoid arthritis and systemic osteoporosis. It is demonstrated that alendronate-based therapy in weekly 1 mg/kg doses over 12 months facilitated reliably increased bonedensity, decreased intensity of pain syndrome, and lowered C-terminal telopeptide serum concentration, which indicates improved bone metabolism processes.Key words: juvenile rheumatoid arthritis, osteoporosis, children, treatment, bisphosphonates, alendronic acid. (Pediatric Pharmacology. - 2010; 7(1):48-54)
Item Description:1727-5776
2500-3089

Similar Items